Akili Inc Stock Current Valuation
| AKLIDelisted Stock | USD 0.43 0.00 0.00% |
Valuation analysis of Akili Inc helps investors to measure Akili's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Akili's price fluctuation is very steady at this time. Calculation of the real value of Akili Inc is based on 3 months time horizon. Increasing Akili's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Akili is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akili Stock. However, Akili's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.43 | Real 0.32 | Hype 0.43 | Naive 0.41 |
The intrinsic value of Akili's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Akili's stock price.
Estimating the potential upside or downside of Akili Inc helps investors to forecast how Akili stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akili more accurately as focusing exclusively on Akili's fundamentals will not take into account other important factors: Akili Inc Company Current Valuation Analysis
Akili's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Akili Current Valuation | (15.56 M) |
Most of Akili's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akili Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Akili Inc has a Current Valuation of (15.56 Million). This is 100.11% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The current valuation for all United States stocks is 100.09% higher than that of the company.
Akili Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akili's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akili could also be used in its relative valuation, which is a method of valuing Akili by comparing valuation metrics of similar companies.Akili is currently under evaluation in current valuation category among its peers.
Akili Fundamentals
| Return On Equity | -0.68 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (28.37) % | |||
| Current Valuation | (15.56 M) | |||
| Shares Outstanding | 78.73 M | |||
| Shares Owned By Insiders | 23.21 % | |||
| Shares Owned By Institutions | 61.47 % | |||
| Number Of Shares Shorted | 271.35 K | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 12.31 X | |||
| Revenue | 1.68 M | |||
| Gross Profit | (118 K) | |||
| EBITDA | (60.14 M) | |||
| Net Income | (59.49 M) | |||
| Cash And Equivalents | 45.62 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 15.48 M | |||
| Debt To Equity | 0.79 % | |||
| Current Ratio | 4.78 X | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | (57.87 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.61) X | |||
| Target Price | 0.65 | |||
| Number Of Employees | 68 | |||
| Beta | 1.73 | |||
| Market Capitalization | 34.1 M | |||
| Total Asset | 80.38 M | |||
| Retained Earnings | (299.78 M) | |||
| Working Capital | 65.06 M | |||
| Net Asset | 80.38 M |
About Akili Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akili Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akili using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akili Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |